SEI Investments stock price target raised to $120 from $118 at Raymond James

Investing.comTuesday, October 14, 2025 at 9:51:49 AM
SEI Investments stock price target raised to $120 from $118 at Raymond James
Raymond James has raised its stock price target for SEI Investments from $118 to $120, reflecting a positive outlook on the company's performance. This adjustment indicates confidence in SEI's growth potential and could attract more investors, highlighting the firm's strong position in the financial services sector.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Raymond James reiterates Market Perform on Advance Auto Parts stock
NeutralFinancial Markets
Raymond James has reiterated its 'Market Perform' rating on Advance Auto Parts stock, indicating a cautious outlook on the company's performance in the market. This decision reflects the analysts' belief that while the stock may not significantly outperform or underperform, it remains stable in the current economic climate. Investors should pay attention to this rating as it can influence trading decisions and market perceptions.
Raymond James lowers Tradeweb Markets stock price target on market share concerns
NegativeFinancial Markets
Raymond James has lowered its price target for Tradeweb Markets due to concerns about the company's market share. This adjustment reflects broader worries in the financial sector about competitive pressures and the potential impact on Tradeweb's growth. Investors should pay attention to these developments as they could influence stock performance and investor confidence.
Hub Group stock rating upgraded by Raymond James on intermodal growth
PositiveFinancial Markets
Hub Group's stock has received an upgrade from Raymond James, highlighting the company's strong performance in the intermodal sector. This upgrade is significant as it reflects confidence in Hub Group's growth potential, particularly in a market that is increasingly leaning towards intermodal transportation solutions. Investors may find this news encouraging as it suggests a positive outlook for the company's future.
MSCI price target raised to $660 from $650 at Raymond James
PositiveFinancial Markets
Raymond James has raised its price target for MSCI from $650 to $660, reflecting a positive outlook for the company's performance. This adjustment indicates confidence in MSCI's growth potential and could influence investor sentiment, making it a noteworthy development in the stock market.
Latest from Financial Markets
Grindr’s Billionaire Shareholder Explores Taking Dating App Private In $3 Billion Deal
PositiveFinancial Markets
Billionaire George Raymond Zage III is considering taking Grindr private in a potential $3 billion deal, with $1 billion in financing already secured. This move could reshape the dating app landscape and enhance Grindr's growth potential, making it an exciting development for users and investors alike.
BHP’s Slattery says Australia must cut red tape, power costs, to compete
PositiveFinancial Markets
BHP's Slattery emphasizes the need for Australia to reduce red tape and power costs to enhance its competitiveness in the global market. This is crucial as it could lead to increased investment and job creation, ultimately benefiting the economy and improving the standard of living for Australians.
Why Obamacare Is Keeping The Government On Shutdown
NeutralFinancial Markets
The ongoing debate over Obamacare is impacting the government's potential shutdown, as Democrats push for increased taxpayer funding for health care subsidies while Republicans resist these demands. This standoff highlights the need for both parties to engage in sensible reforms to address the healthcare system's challenges, which could ultimately benefit millions of Americans relying on these services.
EyePoint Pharmaceuticals prices $150 million public offering
PositiveFinancial Markets
EyePoint Pharmaceuticals has successfully priced a $150 million public offering, a significant move that reflects investor confidence in the company's future. This funding will likely support their ongoing research and development efforts, potentially leading to new treatments in the ophthalmology sector. Such financial backing is crucial for biotech firms as it enables them to innovate and expand their product pipelines, ultimately benefiting patients and shareholders alike.
Indian Equities Could Ride Asian Markets Rally on Fed Rate Cut Hopes
PositiveFinancial Markets
Indian equities are poised to benefit from a potential rally in Asian markets, fueled by hopes of a Federal Reserve rate cut. This news is significant as it suggests a favorable environment for investors, potentially leading to increased market activity and confidence in the Indian economy.
KKR, PAG Near Deal for Sapporo Real Estate for Over $2.6 Billion
PositiveFinancial Markets
KKR and PAG are making headlines with their joint bid to acquire Sapporo Holdings' real estate assets for over $2.6 billion. This deal is significant as it highlights the growing interest in real estate investments, especially in the beverage sector, and could reshape the landscape for Sapporo Holdings, allowing them to focus more on their core business.